期刊文献+

冠心病患者冠状动脉呈弥漫病变的临床特点分析

Clinical Characteristics of Patients with Diffuse Coronary Heart Disease
下载PDF
导出
摘要 随着我国经济的发展和人口老龄化的进程,冠心病发病率逐年升高,同时冠状动脉造影检查发现多支弥漫病变呈增多趋势。冠状动脉弥漫病变患者不仅在再血管化方面需要更多的医疗经费,而术后再狭窄发生率明显增高,有些由于血管全程弥漫狭窄。 Objective To analyze the clinical characteristics of patients with diffuse coronary heart disease. Methods A total of 454 patients with angiographicly confirmed coronary artery disease were retrospectively analyzed, based upon the coronery disease characteristics of angiography. These patients were divided as group Ⅰ (277 patients with diffuse coronery artery disease), group Ⅱ(277 patients with nondiffuse coronery artery disease). The clinical documents, laboratory examination data and coronary angiographies results were compared between group I and group II patients. Results Compared to group Ⅱ, the patients of group I had higher rates of diabetes (40.5% vs. 27.3%,P〈0.01). Serum HDL levels and ApoA levels were significantly lower (HDL, 1.14±0.27 vs. 1.2±0.30, P 〈 0.05 ; ApoA, 1.08±0.11 vs 1.12±0.11, P 〈 0.01), while concentrations of blood ereatinine was higher(92.76±43.54 vs. 83.01±20.82, P=0.00l)in group Ⅰ. Compared to group Ⅱ, the prevalence of three-vessels comnery artery disease were more common in group I(45.4% vs. 14.5%, P 〈 0.001). Conclusions The present study supports the evidence that diabetes mellitns,low serum HDL levels and low APOA levels are important risk factor for more extensive and severity coronary artery atheroscleosis disease.
出处 《心脑血管病防治》 2011年第6期430-432,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 Coronary heart disease ANGIOGRAPHY Extensive and severity coronary artery Coronary heart disease Angiography Extensive and severity coronary artery
  • 相关文献

参考文献10

  • 1ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angiography. A reporl of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) [J]. J Am Coll Cardiol, 1988,12(2) :529 - 545.
  • 2Burke AP, Kolodgie FD, Zieske A, et al. Morphologic Findings of Coronary Atherosclerotic Plaquesin Diabetics A Postmortem Study [ J ]. Arterioscler Thromb Vasc Biol,2004, 24(7) : 1266 - 1271.
  • 3Natali A, Vichi S, Landi P, et al. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome[ J]. Diabetologia,2000, 43(5) :632 - 641.
  • 4邬美翠,陆林,吴立群,胡健,沈卫峰,彭文辉,陈秋静.冠心病合并2型糖尿病冠状动脉造影特点分析[J].上海交通大学学报(医学版),2008,28(9):1196-1197. 被引量:6
  • 5hen SN, Cilingiroglu M, Todd J, et al. Candidate genetic analysis of plasma high-density lipoprotein-cholesteml and severity of coronary atherosclemsis[.I]. BMC Med Genet,2009,10:111.
  • 6Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms[J]. Nat Rev Cardiol, 2011,8(4) :222 - 232.
  • 7Walldius G, Jungner I. The apo B/apo A-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipidlowering therapy-a review of the evidence[J]. J Intern Med,2006,259(5) :493 - 519.
  • 8Snidennan AD, Junger I, Holme I, et al. Errors that result from the TC/ HDL C ratio rather than the apo B/apo A-I ratio to identify the lipoproteinrelated risk of vascular disease[J]. J Intern Med,2006,259(5) :455 - 461.
  • 9Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, et al.The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease[J]. Singapore Med J,2009,50(6) :610 -613.
  • 10Raos V, Strujic BJ. Dyslipoproteinemia and coronary disease[J]. Angiology,2002,53(5) :557 - 562.

二级参考文献10

  • 1高妍.糖尿病与心血管疾病[J].中华内分泌代谢杂志,2005,21(5). 被引量:14
  • 2中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:471
  • 3Burke AP, Kolodgie FD, Zieske A,et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study [J]. Arterioscler Thromb Vasc Biol, 2004,24(7) :1266 - 1271.
  • 4Natali A, Vichi S, Landi P, et al. Coronary atherosclerosis in Type Ⅱ diabetes: angiographic findings and clinical outcome[ J]. Diabetologia, 2000,43 ( 5 ) :632 - 641.
  • 5Takaishi H, Taniguchi T, Fujioka Y, et al. Impact of increasing diabetes on coronary artery disease in the past decade[ J]. J Atheroscler Thromb, 2004,11 (5) :271 -277.
  • 6ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures ( Subcommittee on Percutaneous Transluminal Coronary Angioplasty) [J]. J Am Coll Cardiot, 1988,12(2) :529-545.
  • 7Johansen OE, Birkeland KI. Preventing macrovascular disease in patients with type 2 diabetes mellitus[ J]. Am J Cardiovasc Drugs, 2003,3(4) :283 -297.
  • 8Deedwania PC. Mechanisms of endothelial dysfunction in themetabolicsyndrome [ J ]. Curr Diab Rep, 2003, 3 (4) : 289 - 292.
  • 9Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury [ J ]. Circulation,2006,114 (6) :597 - 605.
  • 10Fonseca V, Desouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes [ J ]. Endocrine Reviews, 2004, 25(1) :153 -175.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部